Skip to main content

Exploring the mechanisms of collaboration between the Tuberculosis and Diabetes Programs for the control of TB-DM Comorbidity in Ghana



To explore the mechanisms of collaboration between the stakeholders, including National Tuberculosis Control Program (NTP) and the Non-Communicable Disease Control and Prevention Program (NCDCP) at the national, regional, and local (health facility) levels of the health care system in Ghana. This is one of the objectives in a study on the “Barriers and Facilitators to the Implementation of the Collaborative Framework for the Care and Control of Tuberculosis and Diabetes in Ghana”


The data analysis revealed 4 key themes. These were (1) Increased support for communicable diseases (CDs) compared to stagnant support for non-communicable diseases (NCDs), (2) Donor support, (3) Poor collaboration between NTP and NCDCP, and (4) Low Tuberculosis-Diabetes Mellitus (TB-DM) case detection.


Non-communicable diseases (NCDs) have been described as a “chronic emergency” requiring urgent global public health action, particularly in low- and middle -income countries (LMICs) [1]. In Africa alone, projections suggest that 23.9 million individuals will be living with diabetes mellitus (DM) by the year 2030 [1]. Given the existing high tuberculosis (TB) burden in LMICs, a simultaneous parallel increase in DM prevalence is expected [2]. This growing public health problem has caught the attention of the global community, culminating in the development of 2030 global strategy aimed at reducing TB incidence and TB mortality by 80% and 90%, respectively [3] Despite these initiatives, the African continent has the second-highest TB burden in the world [3] and Ghana has not been spared from the ravages of the TB burden [3]. In Ghana, the national TB prevalence is 148/100,000 population [3], a situation that is exacerbated by the growing TB-DM co-epidemic, thereby imposing a strain on the health care systems. This phenomenon calls for a radical review of the vertical nature of TB and DM programs in the country [4].

In 2011, the World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (Union) took up the challenge of the rising TB-DM co-epidemic inherently linked to the vertical nature of the TB and DM programs by launching the collaborative framework for care and control of TB and DM [5].

The initiative by the WHO and Union was not new in the Ghanaian context since a comparable country-specific programme had been established seventeen years (1994) earlier. Ghana established the National Tuberculosis Control Program (NTP), as part of the disease control department under the public health division of the Ghana Health Service (GHS), with funding from the government and donor funds [6] and that was some years before the launch of the WHO’s collaborative framework, which took place in 2011. Needless to say, the continued pre-2011 increase in TB-DM comorbidity in Ghana raised questions about the effectiveness of the 1994 program. To date, the NTP in Ghana is responsible for the policy interventions, such as the WHO-Union collaborative framework and proposes policies that the Ministry of Health (MoH) can implement to control TB [7].

Over the past decade, NCDs have become a priority in global health agenda, and Ghana, which has been experiencing a steady increase in NCDs, is no exception [1]. The formation of the NCD Control and Prevention Program (NCDCP) in 1992, under the wing of the GHS, is a sign that Ghana has grappled with these public health challenges for a long time [8]. The program’s mandate is to plan, develop clinical practice guidelines, train, advocate and coordinate NCD activities [8]. Ghana's priority NCDs include hypertension, diabetes, cancers and the chronic respiratory diseases, genetic disorders (sickle cell disease) and injuries [8].

Despite notably limited individual TB/ DM program advancement, the vertical nature of these programs limits the potential contribution of implementing collaborative plans, particularly using the tools provided by the WHO-Union collaborative framework.

This study sought to explore the mechanisms of collaboration between the stakeholders, including NTP and the NCDCP at the national, regional, and local (health facility) levels of the health care system in Ghana.

Main text


Study Setting—This study took place in both Accra, the country’s national capital and the Northern Region (NR) of Ghana. Accra is the capital city of Ghana, where national offices of the NTP and the NCDCP are located. The Northern Regional offices of these institutions are in Tamale, the regional capital and the TB and DM units are located at the three health facilities in the Northern region.

Study Design- Guided by the grounded theory design, this study explored the mechanisms of collaboration between NTP and NCDCP programs in Ghana at the levels of national, regional and health facilities, using key- informant interviews. Ethical approval was obtained from both the University of KwaZulu-Natal (UKZN) Biomedical Research Ethics Committee (BREC) (BE262/19) and Ghana Health Service Ethics Review Committee (GHSERC) (GHS-ERC 012/04/19). The researcher obtained permission and introductory letters from the GHS and presented at the NTP and NCDCP national and regional offices in Accra and Tamale, respectively, as well as the three health facilities in the Northern Region. As a gesture of study endorsement, the directors of the programs introduced the researcher to the program officers who met the selection criteria for inclusion into the study. At the health facilities, the medical directors introduced the researcher to the staff of TB and DM units.

Data generation—Twelve (12) purposively selected key informants were interviewed by the researcher, face-to-face at two locations, namely: Accra and Tamale. Two participants were recruited from NTP (national and regional), two from the NCDCP (national and regional) and eight participants from the three health facilities. All respondents read the information sheet and signed informed consent prior to being interviewed. In-depth interviews lasted for 30–45 min and were audio-recorded (with participants’ permission). Two participants consented to the study, but objected to being audio-recorded, hence their interviews were only recorded through the hand-written notes. All the interviews were conducted in English, as all the participants were comfortable with English language. The researcher also took the summary notes during all the interviews. The semi-structured interview guides (Additional files 1 and 2) covered questions on existing policies to establish the mechanism of collaboration, state of TB-DM at both the national and regional levels, stakeholder inputs into the policy process and coordination of activities between NTP and NCDCP.

Data Analysis—Using the grounded theory analytical approach, the digital audio recordings from the interviews were carefully transcribed in verbatim by a professional transcriber and the researcher, who has training in qualitative research methods, verified transcriptions, to confirm data quality. Furthermore, the researcher meticulously read through all the transcripts and compared them with field notes and audio-records, to ensure the integrity of data. Recurring ideas were grouped into themes, and emerging themes were coded manually by the researcher. Similar codes were grouped under major themes—the analysis generated 4 main themes.


The key informants in this study were staff of the NTP and NCDCP at the national and regional offices, Hospital managers and TB and DM Unit managers in three health facilities. A total of 12 participants comprised of National program managers (n = 2), Regional program managers (n = 2), Hospital managers (n = 2), TB unit manager (n = 3), and DM unit managers (n = 3) (Table 1).

Table 1 Characteristics of the study participants

Participants’ responses reflected their perception of the extent of integration, challenges, and opportunities to implementing the collaborative framework (Table 2). The main themes from the analysis were (1) Increased support for communicable diseases compared to stagnant support for non-communicable diseases, (2) Donor support (3), Poor collaboration between NTP and NCDCP, and (4) Low TB-DM Case detection.

Table 2 Themes and quotes from participants on mechanism of collaboration

The results of this study revealed that NTP introduced task-shifting officers in some facilities to circumvent the additional burden imposed by screening on the nurses (Participant 1).

Research participants who were the custodians of the policy (national level) identified the dependency on donor support to fund the NCDCP as one of the key challenges, which negatively affected the TB-DM collaboration (Participant 2). The fact that donor support was mainly targeted at health conditions, like maternal and child health, did not advance the agenda of TB-DM collaboration (Participant 4).

Findings from this study showed no evidence of collaboration between the NTP and NCDCP at the national and regional levels (Participant 2, & 7). However, at the facility level, some pockets of informal collaboration were observed, however, these were based on the healthcare workers’ personal initiatives (Participant 2).

Respondents attributed low TB-DM detection to poor screening among DM patients (Participants 2), limited DM clinics in most health facilities (participant 1) and limited data for TB-DM comorbidity, mainly due to the lack of designated diabetic clinics in most health facilities (participant 3).


To the best of our knowledge, this is the first study to explore the mechanisms of collaboration between the NTP and NCDCP at the national, regional, and local levels, using qualitative methods.

Health care systems in resource-constrained settings are grappling with responding to the co-existence of both CDs and NCDs in the same populations or individuals, hence our findings have reiterated that there still exists an imbalance between health delivery for CDs and NCDs in Ghana [9]. The findings of this study found that the delivery of care was biased towards CDs. This was supported by views expressed in this study showing that NCDs were not a top priority as CDs. These findings are consistent with the results of a study previously conducted in Ghana, confirming that diagnostic and care services to infectious diseases are more accessible than that of NCDs[10]. This may be due to the health system structure in Ghana, which is generally skewed towards managing CDs, a phenomenon that is not peculiar to the Ghanaian context, as it has also been reported in other low-to-middle-income countries [10,11,12]. In Ethiopia and India, there was poor quality of care for DM patients, and NCD services lacked systems for monitoring and evaluation [13, 14]. Along the same lines, Critchley and colleagues [15] shared that there is considerable support and funding for TB treatment by the WHO, and this is in contrast to financially deprived DM care in LMICs [15]. Limited health insurance is available for DM care in LMICs, leading to high out of pocket cost and poor outcomes in detection and management of DM patients [15, 16]. Further studies in Ghana and Bangladesh highlighted the lack of infrastructure, guidelines, and supplies to be able to deliver NCD care [10, 12].This study found that healthcare workers were concerned that screening of patients was an additional responsibility to their existing workload, and this was consistent with the findings of other studies [16]. However, in Ghana, the NTP with funding from the Global Fund augmented this by recruiting extra staff as task shifting officers to support the integration.

According to participants’ views, donor support was a critical source of funding to complement the limited budget of the MoH/GHS. This funding from donors was largely tied to specific health conditions and outcomes, which influenced the strategic direction of the diseases program in receipt of the funding. The reliance on donor support may be due to the limited national budgets for health ministries which were not a priority for funding in comparison with other ministries as observed by Puchner et al. [2]. In Kyrgyzstan, funding for TB was 44% financed by external donors with diabetes receiving no direct external funding [17].

The low TB-DM case detection may be due to the limited collaboration between the NTP and NCDCP at all levels of the healthcare system. This research found that integration at the program levels was largely hindered because of sources of funding and structured objectives of the programs, which did not leave room for integrating other health conditions. Therefore, funding appears to be one of the most important factors that would influence the mechanism of collaboration between NTP and NCDCP. Currently, the screening for DM is seen as burdensome due to poor funding of DM programs.

Additionally, the low awareness of the TB-DM comorbidity and how to integrate services was adversely affecting the rate of case detection, as reported in other research conducted in Ghana [18]. According to a publication on Ghana's NCD policy, poor screening is also attributable to low awareness of implementers in the northern region [19].


There exist limited mechanisms of collaborations between the NTP and NCDCP mainly at the health facility level, with the lack of funding identified as one of the important impediments. There is still a gap at the national and regional program levels with regards to joint coordination of activities geared towards TB and DM collaboration. Therefore, the results of this study can be used to advocate for better TB-DM collaboration and lobby policymakers and politicians to prioritise integrative services for these two health conditions. Development of different health insurance schemes for DM patients may potentially help support in the high cost of DM care, as suggested by some study participants. Further awareness and training are required on the TB-DM comorbidity, and the recommendations by the WHO collaborative framework for the care and control of TB and DM will promote further integration. Lastly, there is a need for advocacy groups to highlight the importance of prioritizing DM, alongside TB, in donor funding, to circumvent low uptake of DM screening services and improve DM health outcomes.


  • This study was confined to key informants and may have benefited from a larger group of stakeholders working in the non-governmental health sector.

  • The study was unable to explore the collaboration of the TB and DM programs at the district and sub district levels of Ghana.

Availability of data and materials

All data generated or analyzed during this study are included in this published article [and its additional files].



Communicable Diseases


Diabetes mellitus


Ghana Health Service


Human Immunodeficiency Virus


Low- and Middle-Income Countries


Ministry of Health


Non-Communicable Diseases


Non-communicable Disease Control and Prevention Program


Ghana National Tuberculosis Control Program






International Union Against Tuberculosis and Lung Disease


World Health Organization


  1. Bosu WK. Accelerating the control and prevention of non-communicable diseases in Ghana: the key issues. Postgraduate Med J Ghana. 2013;2(1):32–3.

    Google Scholar 

  2. Puchner KP, Rodriguez-Fernandez R, Oliver M, Solomos Z. Non-communicable diseases and tuberculosis: anticipating the impending global storm. Glob Public Health. 2019;14(9):1372–81.

    Article  Google Scholar 

  3. WHO. Global tuberculosis report World Health Organization. Geneva: World Health Organization; 2019.

    Google Scholar 

  4. Harries A, Kumar A, Satyanarayana S, Lin Y, Zachariah R, Lönnroth K, et al. Diabetes mellitus and tuberculosis: programmatic management issues. Int J Tuberc Lung Dis. 2015;19(8):879–86.

    Article  CAS  Google Scholar 

  5. WHO. Collaborative framework for care and control of tuberculosis and diabetes. Geneva: World Health Organization; 2011.

    Google Scholar 

  6. Amo-Adjei J. Political commitment to tuberculosis control in Ghana. Glob Public Health. 2014;9(3):299–311.

    Article  Google Scholar 

  7. Amo-Adjei J, Awusabo-Asare K. Reflections on tuberculosis diagnosis and treatment outcomes in Ghana. Arch Public Health. 2013;71(1):22.

    Article  Google Scholar 

  8. Bosu WK. A comprehensive review of the policy and programmatic response to chronic non-communicable disease in Ghana. Ghana Med J. 2012;46(2):69–78.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Marais BJ, Lönnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis. 2013;13(5):436–48.

    Article  Google Scholar 

  10. Kushitor MK, Boatemaa S. The double burden of disease and the challenge of health access: evidence from access, bottlenecks, cost and equity facility survey in Ghana. PLoS ONE. 2018;13(3):e0194677.

    Article  Google Scholar 

  11. Temu F, Leonhardt M, Carter J, Thiam S. Integration of non-communicable diseases in health care: tackling the double burden of disease in African settings. Pan Afr Med J. 2014;18:202.

    Article  Google Scholar 

  12. Rawal LB, Kanda K, Biswas T, Tanim MI, Poudel P, Renzaho AM, et al. Non-communicable disease (NCD) corners in public sector health facilities in Bangladesh: a qualitative study assessing challenges and opportunities for improving NCD services at the primary healthcare level. BMJ Open. 2019;9(10):e029562.

    Article  Google Scholar 

  13. Sharma P, Visnegarwala F, Tripathi V. Burgeoning double burden of tuberculosis and diabetes in India: magnitude of the problem–Strategies and solutions. Clin Epidemiol Global Health. 2014;2(3):107–16.

    Article  Google Scholar 

  14. Workneh MH, Bjune GA, Yimer SA. Assessment of health system challenges and opportunities for possible integration of diabetes mellitus and tuberculosis services in South-Eastern Amhara Region, Ethiopia: a qualitative study. BMC Health Serv Res. 2016;16(1):1–11.

    Article  Google Scholar 

  15. Critchley JA, Restrepo BI, Ronacher K, Kapur A, Bremer AA, Schlesinger LS, et al. Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 1: epidemiology and clinical management. Chest. 2017;152(1):165–73.

    Article  Google Scholar 

  16. Riza AL, Pearson F, Ugarte-Gil C, Alisjahbana B, van de Vijver S, Panduru NM, et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol. 2014;2(9):740–53.

    Article  Google Scholar 

  17. Skordis-Worrall J, Round J, Arnold M, Abdraimova A, Akkazieva B, Beran D. Addressing the double-burden of diabetes and tuberculosis: lessons from Kyrgyzstan. Glob Health. 2017;13:1–9.

    Article  Google Scholar 

  18. Obirikorang Y, Obirikorang C, Anto EO, Acheampong E, Batu EN, Stella AD, et al. Knowledge of complications of diabetes mellitus among patients visiting the diabetes clinic at Sampa Government Hospital, Ghana: a descriptive study. BMC Public Health. 2016;16(1):637.

    Article  Google Scholar 

  19. Nyaaba GN, Stronks K, Masana L, Larrea-Killinger C, Agyemang C. Implementing a national non-communicable disease policy in sub-Saharan Africa: experiences of key stakeholders in Ghana. Health Policy Open. 2020;1:100009.

    Article  Google Scholar 

Download references


We are thankful to the University of KwaZulu-Natal, College of Health Sciences for providing funding for this study. We would also like to thank the staff of the NTP, NCDCP and the hospitals who participated in this study.


This study is funded by the University of KwaZulu-Natal, College of Health Sciences Research Scholarship.

Author information

Authors and Affiliations



RS conceptualized the study and wrote the research proposal. KWH contributed to the writing and critically reviewed the draft. RS wrote the final manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Rita Suhuyini Salifu.

Ethics declarations

Ethics approval and consent to participate

Participants in this study signed informed consent forms. Ethical approval was from the University of KwaZulu-Natal (UKZN) Biomedical Research Ethics Committee (BREC) (ref.BE262/19) and Ghana Health Service Ethics Review Committee (GHSERC) (GHS-ERC 012/04/19).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Interview guide 1-Health Managers.

Additional file 2.

Interview guide 2- Policy Makers.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salifu, R.S., Hlongwana, K.W. Exploring the mechanisms of collaboration between the Tuberculosis and Diabetes Programs for the control of TB-DM Comorbidity in Ghana. BMC Res Notes 14, 217 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: